The announcement came after GSK said on Jan. 15 that Unilever’s bid was unsolicited and undervalued the consumer healthcare business.
Unilever said it understood GSK’s value, but remained committed to its bid, as the company is “committed to maintaining strict financial discipline to ensure that acquisitions create value for our shareholders,” according to the article.
In a response to The Wall Street Journal, Unilever said it remains committed to building a future in the consumer healthcare business.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.